Biomedical patents and the public's health: is there a role for eminent domain?
Kesselheim
Aaron S
AS
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA. akesselheim@partners.org
Avorn
Jerry
J
D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D019981:Health Care Sector / Q000941:ethics / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000941:ethics / Q000331:legislation & jurisprudence*; D011634:Public Health / Q000941:ethics / Q000331:legislation & jurisprudence*; D014481:United States